Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China

Documenti analoghi

• The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
  di: Yiming Mu
  Pubblicazione: (2024)
• Glycaemic Outcomes of a Novel Model‐Predictive‐Control‐Based Hybrid Closed‐Loop System in Chinese Adolescents and Adults With Type 1 Diabetes: A Multicentre Pivotal Trial
  di: Yang Liu, et al.
  Pubblicazione: (2026)
• Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems
  di: Lauren V. Turner, et al.
  Pubblicazione: (2024)
• Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
  di: Melissa‐Rosina Pasqua, et al.
  Pubblicazione: (2025)
• No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
  di: Andrzej S. Januszewski, et al.
  Pubblicazione: (2025)